Allogeneic Human Mesenchymal Stem Cells for Alzheimer’s Disease

This is a Phase IIa, multi-center, randomized, single-blind, placebo-controlled, crossover study to assess the safety, tolerability, and preliminary efficacy of a single intravenous dose of allogeneic human mesenchymal stem cells in subjects with mild to moderate dementia due to Alzheimer’s disease.

Learn More